Global Health IPO Date, Price, Review
Global Health IPO: Know everything about Medanta IPO aka Global Health Limited IPO. Global Health International Limited IPO Date, Global Health Ltd IPO Review and analysis. We will discus about Global Health IPO Benefits & Risks. Also, all information related to Global Health IPO like price band, all important dates, issue size, Brockrage Review, and retail quota etc.
Global Health IPO
Global Health Limited, which operates under the Medanta brand, has emerged as one of the largest private multi-specialty tertiary care providers in the North and East regions of India. Global Health Ltd Has filed its DRHP (Draft Red Herring Prospectus) with market regulator SEBI (Securities and Exchange Board of India) to raise around Rs 2205.57 crore through IPO (Initial public offering).
Global Health IPO will open on 03 November 2022 and close on 07 November 2022. The price band of the Global Health IPO is ₹319 to ₹336. Global Health IPO size is 2205.57 Crores. The offer includes ₹500 Crores under fresh issue and 1705.57 Crores under offer for sale. Global Health IPO QIB quota is 50%, NII quota is 15% and RII quota is 35%. Global Health IPO listing date is 16 November 2022. You can know about Global Health IPO GMP (Grey Market Premium) below.
Global Health has given good financial performance. The company made a profit of ₹196.2 crores in the financial year 2022 (March 2022). The IPO of Global Health will be listed on NSE and BSE. Global Health IPO face value is ₹2 per equity share.
We will talk about Global Health limited' financials, benefits, and risks of investing in the company.
About Global Health International Ltd
Global Health Limited operates and manages Medanta Hospitals. Medanta was started in the year 2009. Since then Medanta has emerged as the best private hospital in India due to the continuous efforts of the company. Global Health Limited has carved a niche for itself as one of the largest private multi-specialty tertiary care providers primarily in the North and East regions of India.
Global Health Limited's core expertise includes Cardiology and Cardiac Sciences, Neurosciences, Orthopedics, Liver Transplant, Oncology, Digestive and Hepatobiliary Sciences, and Kidney and Urology. Presently Global Health Limited operates a network of four hospitals under the brand "Medanta" at Indore, Gurugram, Ranchi, and Lucknow.
If we talk about the financial performance of the company, then Rs 14,805.71 million in the financial year 2020, and Rs 14,178.41 million in the year 2021. and 21,003.95 million in 2022, Rs. income is earned.
Purpose of the offer
- To prepay/repay all or a part of the dues raised by the company.
- To finance capital expenditure requirements for the purchase of new machinery.
- To meet general corporate objectives.
Global Health IPO Date and Price Band Details
IPO Open: | 03 November 2022 |
IPO Close: | 07 November 2022 |
Listing Date: | 16 November 2022 |
Listing On: | NSE & BSE |
IPO Size: | Approx ₹2205.57 crores |
Fresh Issue: | Approx ₹500 crores |
Offer For Sale: | Approx ₹1705.57 |
Price Band: | ₹319 to ₹336 per share |
Face Value: | ₹2 per Equity share |
QIB Portion: | 50% |
Retail Portion: | 35% |
NII Portion: | 15% |
Employee Res: | Not Disclosed |
Global Health IPO Lot Size Details
Minimum Lot: | 01 |
Minimum Lot Size: | 44 Shares |
Minimum Amount: | ₹14,784 |
Maximum Lot: | 13 |
Maximum Lot Size: | 572 Shares |
Maximum Amount: | ₹192,192 |
Global Health IPO Open, Close, Allotment, and Listing Date
Ipo Opening Date: | 03 November 2022 |
IPO Closing Date: | 07 November 2022 |
Basis of Allotment: | 11 November 2022 |
Refund Date: | 14 November 2022 |
Credit to Demat Account: | 15 November 2022 |
Listing Date: | 16 November 2022 |
Global Health IPO Review
Happiest Post | Not Rated yet |
Anand Rathi | Not Rated yet |
Angle One | Not Rated yet |
Axis Capital | Not Rated yet |
HDFC Securities | Not Rated yet |
ICICI Direct | Not Rated yet |
Kotak Securities | Not Rated yet |
Motilal Oswal | Not Rated yet |
Sharekhan | Not Rated yet |
You can also check the latest IPO subscription status and IPO allotment status of Global Health IPO on our website.
Global Health Ipo Rating
Review For Listing Gain
Review For Short term
Review For Long term
Strength
- The company has a wide range of medical expertise including Cardiology and Cardiac Sciences, Neurosciences, Liver Transplant, Oncology, Orthopedics, Digestive and Hepatobiliary Sciences, and Kidney and Urology.
- The company is the leading tertiary and quaternary care provider in India.
- Additionally, the company enjoys a reputation for clinical excellence.
- The main focus areas of the company are clinical research and academia.
- The company has had solid operating and financial performance in the past.
- The company is focusing on expanding existing facilities into new services, including digital health.
Risks
- Doctors, nurses, and other healthcare workers are very important to the company, which could have a negative impact if the company loses under any circumstances.
- Certain assets on which the Company's hospital facilities and clinics are located are not owned or leased on a long-term basis by the Company.
- Companies depend on the bank or financial institution financing to further expand their activities.
- There is a pending suit against the company, against their directors, subsidiaries, and promoter, if they do not come in favor of the company then it may have a negative impact on the company.
Global Health Ltd Financials
Global Health Financials(in Crores)
Year | Total Assets | Revenue | Profit |
---|---|---|---|
2019 | ₹2,430.00 | ₹1,505.99 | ₹51.30 |
2020 | ₹2,666.29 | ₹1,544.27 | ₹36.33 |
2021 | ₹2,694.10 | ₹1,478.16 | ₹28.80 |
2022 | ₹3145.52 | ₹2205.82 | ₹196.2 |
Promoters
- Naresh Trehan
Contact Details of Global Health
Medanta – Mediclinic, E-18,
Defence Colony, New Delhi,
Delhi 110 024, India
Telephone: +91 124 483 4060
E-mail: compliance@medanta.org
Website:www.medanta.org
Global Health Lead Managers
- JM Financial Limited
- Jefferies India Private Limited
- Kotak Mahindra Capital Company Limited
- Credit Suisse Securities (India) Private Limited
Global Health IPO Registrars
Selenium, Tower-B
Plot 31 and 32, Financial District
Nanakramguda, Serilingampally
Hyderabad, Rangareddi 500 032
Telangana, India
Telephone: +91 40 6716 2222
Email: globalhealth.ipo@kfintech.com
Website:www.kfintech.com
Conclusion
There are some good and some bad things in the company. Looking at the financial position of the company, the company has been profitable for the last several financial years. In the financial year 2019, the company had a profit of 51.30 crores, while in the financial year 2021, the company's profit decreased to 28.80 crores. The company had a profit of Rs 196.2 crore in the financial year 2022. The company operates its business under the brand name Medanta. Our suggestion will be updated when the Global Health Limited IPO begins. Global Health Limited IPO financial statement and other information are provided above.
Global Health IPO FAQs
How to Apply the Global Health Ltd IPO with Zerodha?
We hope you like this article about Global Health IPO. If you have a query about Global Health IPO then, leave a comment. Here you can also stay updated about the upcoming IPO. Also, you can track IPO performance. Thanks for Visiting. Happy Investing.
0 Comments
We are waiting for your comments. 💙